3.9 Article

Skp2 Is Required for Incretin Hormone-Mediated β-Cell Proliferation

Journal

MOLECULAR ENDOCRINOLOGY
Volume 25, Issue 12, Pages 2134-2143

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/me.2011-1119

Keywords

-

Funding

  1. National Institutes of Health [R01 DK-068763]
  2. Helmsley Trust
  3. Juvenile Diabetes Research Foundations
  4. National Institute of Diabetes and Digestive and Kidney Diseases

Ask authors/readers for more resources

The glucoincretin hormone glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (Ex-4) promote beta-cell growth and expansion. Here we report an essential role for Skp2, a substrate recognition component of SCF (Skp, Cullin, F-box) ubiquitin ligase, in promoting glucoincretin-induced beta-cell proliferation by regulating the cellular abundance of p27. In vitro, GLP-1 treatment increases Skp2 levels, which accelerates p27 degradation, whereas in vivo, loss of Skp2 prevents glucoincretin-induced beta-cell proliferation. Using inhibitors of phosphatidylinositol 3-kinase and Irs2 silencing RNA, we also show that the effects of GLP-1 in facilitating Skp2-dependent p27 degradation are mediated via the Irs2-phosphatidylinositol-3 kinase pathway. Finally, we show that down-regulation of p27 occurs in islets from aged mice and humans, although in these islets, age-dependent accumulation of p16(Ink4a) prevent glucoincretin-induced beta-cell proliferation; however, ductal cell proliferation is maintained. Taken together, these data highlight a critical role for Skp2 in glucoincretin-induced beta-cell proliferation. (Molecular Endocrinology 25:2134-2143, 2011)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available